Botulinum Toxin for Borderline Personality Disorder?
In a small open-label case series, patients with borderline personality disorder benefited from botulinum toxin injections.
Lamotrigine: Brand-Name versus Generic
Two studies found no significant changes in blood levels or pharmacokinetic variables when patients with seizure disorders were switched between brand-name lamotrigine (Lamictal and others) and various generic formulations.
Drugs to Help Smokers Quit: New Data
A new study comparing varenicline (Chantix) and bupropion (Wellbutrin, Zyban, and others) with a nicotine patch and placebo in smokers with and without psychiatric diagnoses reports no significant difference in neuropsychiatric adverse events among the four treatment groups.
Antipsychotics, Pneumonia, and Alzheimer Disease
A large study in Finland found that antipsychotic use was associated with an increased risk of pneumonia both in patients with and those without Alzheimer disease.
Children with Hypertension Score Lower on Neurocognitive Tests; Use of Hormonal Contraception in Women Linked to Depression
BTP's 40th Year
The next issue of this newsletter, January 2017, will mark the start of our 40th annual volume.
Please be sure to submit the Continuing Medical Education (CME) posttest and evaluation for 2016. You can complete the test online or print it out and then submit by email or fax.
the source for
up-to-date information on psychotropic medications and other biological treatments for mental disorders
Register now, or if you are completing your residency and received a promotional mailing, enter your code.
Subscribing to BTP is easy! You can receive the print version with online access, or online only.
- J. Rutherford, M.D.